查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612566

生物样本处理市场：按类型、产品类型、最终用途、应用分类 - 2025-2030 年全球预测

Biological Sample Handling Market by Type (Cellular & Genetic Material, Saliva Samples, Stool Samples), Product (Blood Collection Kits, Swabs, Viral Transport Media), End-Use, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物样本处理市场价值为186.2亿美元，预计到2024年将达到198.5亿美元，复合年增长率为6.47%，到2030年将达到288.8亿美元。

生物样本处理市场包括有效管理、处理和保存生物样本所需的广泛活动。这个过程对于保持诊断测试、药物发现和生物样本库中使用的样本的完整性和活力至关重要。临床试验、流行病学研究和个人化医疗对准确可靠结果的需求不断增长，因此需要强大的样本处理实践。样本处理应用范围广泛，包括临床实验室、医院、研究机构和製药公司。影响成长的关键因素包括慢性病的增加、生物技术的进步以及需要高品质样本管理的基因组研究的扩展。此外，精准医疗和个人化医疗日益受到关注，需要加强处理程序。自动化和创新技术有新的机会，例如冷冻保存和自动储存系统，可显着提高样品管理的效率。公司可以透过利用区块链实现资料和利用人工智慧进行预测样本分析等领域来获得竞争优势。然而，市场开拓的挑战包括严格的监管要求、与先进处理技术相关的高成本以及新兴地区的意识有限。品管问题也对市场开拓构成重大风险。最佳创新领域包括改进永续性实践、整合物联网进行即时监控以及增强生物资讯学以实现更好的资料管理。研究新的保存方法以及开发环保且具成本效益的保存解决方案也可以推动成长。该市场本质上是高度动态的，重点关注技术进步和主要企业之间的伙伴关係，以简化业务并扩大其影响范围。为了缓解挑战并有效抓住新机会，企业应优先考虑持续创新和策略联盟。

主要市场统计
基准年[2023] 186.2亿美元
预计年份 [2024] 198.5亿美元
预测年份 [2030] 288.8亿美元
复合年增长率（%） 6.47%

市场动态：揭示快速发展的生物样本处理市场的关键市场洞察

供需的动态交互作用正在改变生物样本处理市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 个人化医疗保健中对液体样本管理和处理的需求不断增加
    • 基因组学和蛋白​​质组学的需求不断增长以及生物银行的增加
    • 生物标记分析的快速增长和对先进样品处理的需求
  • 市场限制因素
    • 与生物样品处理相关的严格规定
  • 市场机会
    • 增加对生命科学研发活动的投资
    • 样品处理的技术进步与创新
  • 市场挑战
    • 操作复杂性和对特定处理通讯协定的需求

波特五力：驾驭生物样本处理市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解生物样本处理市场的外部影响

外部宏观环境因素在塑造生物样本处理市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解生物样本处理市场的竞争格局

对生物样本处理市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵生物样本处理市场供应商的绩效评估

FPNV 定位矩阵是评估生物样本处理市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製生物样本处理市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对生物样本处理市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 个人化医疗保健中对体液样本管理和处理的需求不断增加
      • 基因组学和蛋白​​质组学的需求不断增长以及生物银行实践的增加
      • 生物标记分析快速增加以及对先进样品处理的需求
    • 抑制因素
      • 与生物样品处理相关的严格规定
    • 机会
      • 增加对生命科学研发活动的投资
      • 样品处理的技术进步与创新
    • 任务
      • 操作复杂性和对特定处理通讯协定的需求
  • 市场区隔分析
    • 产品：更多使用采血套件和拭子在运输过程中保存病毒样本
    • 最终用途：在医院中更多地采用生物样本处理解决方案，促进主动的健康管理
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章生物样本处理市场：依类型

  • 细胞和遗传物质
  • 唾液样本
  • 粪便样本
  • 尿液样本

第七章生物样本处理市场：副产品

  • 血液采集套件
  • 棉花棒
    • 鼻拭子
    • 鼻咽拭子
    • 口咽拭子
  • 病毒运输媒介

第八章生物样本处理市场：依最终用途

  • 诊断中心
  • 居家护理
  • 医院/诊所

第九章生物样本处理市场：依应用分类

  • 诊断
  • 调查

第10章美洲生物样本处理市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区生物样本处理市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的生物样本处理市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • MedLife 使用无人机运输实验室样本
    • BioLizard 与 Parean Biotechnologies 宣布合作
    • MolGen 收购 Synchron Lab Automation
  • 战略分析和建议

公司名单

  • Accelerated Laboratory Logistics
  • Alliance Pharma PLC
  • Azenta Life Sciences
  • BioDock Limited
  • BioLife Solutions Inc.
  • Clinigen Group
  • Cryoniss
  • Cryoport Systems, LLC
  • Discovery Life Sciences
  • Eppendorf SE
  • Hamilton Company
  • Infiuss Health
  • Labtoo
  • Marken by United Parcel Service, Inc.
  • Mercury Business Services
  • MLM Medical Labs
  • Oximio
  • PrecisionMed, LLC
  • ReproCELL Inc.
  • SAROUTE Co., Ltd.
  • SPT Labtech Ltd.
  • Thermo Fisher Scientific Inc.
  • Ziath Ltd.
Product Code: MRR-757B1C9CB0B6

The Biological Sample Handling Market was valued at USD 18.62 billion in 2023, expected to reach USD 19.85 billion in 2024, and is projected to grow at a CAGR of 6.47%, to USD 28.88 billion by 2030.

The biological sample handling market encompasses a wide range of activities necessary for the effective management, processing, and preservation of biological samples. This process is vital for maintaining the integrity and viability of samples used in diagnostic testing, drug discovery, and biobanking. The necessity of robust sample handling practices arises from the increased demand for precise and reliable results in clinical trials, epidemiological studies, and personalized medicine. Applications of sample handling are broad, spanning clinical laboratories, hospitals, research institutions, and pharmaceutical companies. Key influencing growth factors include the rise in chronic diseases, advancements in biotechnologies, and the expansion of genomic research requiring high-quality sample management. Also noteworthy is the burgeoning interest in precision medicine and personalized healthcare, necessitating enhanced handling procedures. Emerging opportunities exist in automation and innovative technologies like cryopreservation and automated storage systems, which can greatly enhance sample management efficiency. Companies can capitalize on areas such as blockchain for data integrity and AI for predictive sample analytics to gain a competitive edge. However, challenges to market growth include stringent regulatory requirements, high costs associated with advanced handling technologies, and limited awareness in developing regions. Quality control issues also pose a substantial risk to market development. The best areas for innovation involve improving sustainability practices, integrating IoT for real-time monitoring, and enhancing bioinformatics for better data management. Research into novel preservation methods and the development of eco-friendly, cost-effective storage solutions can also foster growth. The market is highly dynamic in nature, with a focus on technological advancements and partnerships among key players to streamline operations and expand reach. Businesses should prioritize continuous innovation and strategic collaborations to mitigate challenges and leverage emerging opportunities effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 18.62 billion
Estimated Year [2024] USD 19.85 billion
Forecast Year [2030] USD 28.88 billion
CAGR (%) 6.47%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biological Sample Handling Market

The Biological Sample Handling Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for fluid sample management and handling in personalized healthcare
    • Growing demand from genomics and proteomics and the rise in biobanking practices
    • Exponential growth of biomarker analysis and the need for sophisticated sample handling
  • Market Restraints
    • Strict regulations associated with biological sample handling
  • Market Opportunities
    • Increasing investment in life sciences R&D activities
    • Technological advancements and innovations in sample handling
  • Market Challenges
    • Complexity associated with operations and need for specific handling protocols

Porter's Five Forces: A Strategic Tool for Navigating the Biological Sample Handling Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biological Sample Handling Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biological Sample Handling Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biological Sample Handling Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biological Sample Handling Market

A detailed market share analysis in the Biological Sample Handling Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biological Sample Handling Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biological Sample Handling Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biological Sample Handling Market

A strategic analysis of the Biological Sample Handling Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biological Sample Handling Market, highlighting leading vendors and their innovative profiles. These include Accelerated Laboratory Logistics, Alliance Pharma PLC, Azenta Life Sciences, BioDock Limited, BioLife Solutions Inc., Clinigen Group, Cryoniss, Cryoport Systems, LLC, Discovery Life Sciences, Eppendorf SE, Hamilton Company, Infiuss Health, Labtoo, Marken by United Parcel Service, Inc., Mercury Business Services, MLM Medical Labs, Oximio, PrecisionMed, LLC, ReproCELL Inc., SAROUTE Co., Ltd., SPT Labtech Ltd., Thermo Fisher Scientific Inc., and Ziath Ltd..

Market Segmentation & Coverage

This research report categorizes the Biological Sample Handling Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Cellular & Genetic Material, Saliva Samples, Stool Samples, and Urine Samples.
  • Based on Product, market is studied across Blood Collection Kits, Swabs, and Viral Transport Media. The Swabs is further studied across Nasal Swabs, Nasopharyngeal Swabs, and Oropharyngeal Swabs.
  • Based on End-Use, market is studied across Diagnostic Centers, Homecare, and Hospitals & Clinics.
  • Based on Application, market is studied across Diagnostics and Research.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for fluid sample management and handling in personalized healthcare
      • 5.1.1.2. Growing demand from genomics and proteomics and the rise in biobanking practices
      • 5.1.1.3. Exponential growth of biomarker analysis and the need for sophisticated sample handling
    • 5.1.2. Restraints
      • 5.1.2.1. Strict regulations associated with biological sample handling
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment in life sciences R&D activities
      • 5.1.3.2. Technological advancements and innovations in sample handling
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity associated with operations and need for specific handling protocols
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing usage of blood collection kits and swabs for preserving viral samples during transportation
    • 5.2.2. End-Use: Increasing adoption of biological sample handling solutions in hospitals promoting proactive health management
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biological Sample Handling Market, by Type

  • 6.1. Introduction
  • 6.2. Cellular & Genetic Material
  • 6.3. Saliva Samples
  • 6.4. Stool Samples
  • 6.5. Urine Samples

7. Biological Sample Handling Market, by Product

  • 7.1. Introduction
  • 7.2. Blood Collection Kits
  • 7.3. Swabs
    • 7.3.1. Nasal Swabs
    • 7.3.2. Nasopharyngeal Swabs
    • 7.3.3. Oropharyngeal Swabs
  • 7.4. Viral Transport Media

8. Biological Sample Handling Market, by End-Use

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Homecare
  • 8.4. Hospitals & Clinics

9. Biological Sample Handling Market, by Application

  • 9.1. Introduction
  • 9.2. Diagnostics
  • 9.3. Research

10. Americas Biological Sample Handling Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biological Sample Handling Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biological Sample Handling Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. MedLife to Transport Lab Samples with Drones
    • 13.3.2. BioLizard and Parean Biotechnologies Announce Partnership
    • 13.3.3. MolGen Acquires Synchron Lab Automation
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accelerated Laboratory Logistics
  • 2. Alliance Pharma PLC
  • 3. Azenta Life Sciences
  • 4. BioDock Limited
  • 5. BioLife Solutions Inc.
  • 6. Clinigen Group
  • 7. Cryoniss
  • 8. Cryoport Systems, LLC
  • 9. Discovery Life Sciences
  • 10. Eppendorf SE
  • 11. Hamilton Company
  • 12. Infiuss Health
  • 13. Labtoo
  • 14. Marken by United Parcel Service, Inc.
  • 15. Mercury Business Services
  • 16. MLM Medical Labs
  • 17. Oximio
  • 18. PrecisionMed, LLC
  • 19. ReproCELL Inc.
  • 20. SAROUTE Co., Ltd.
  • 21. SPT Labtech Ltd.
  • 22. Thermo Fisher Scientific Inc.
  • 23. Ziath Ltd.

LIST OF FIGURES

  • FIGURE 1. BIOLOGICAL SAMPLE HANDLING MARKET RESEARCH PROCESS
  • FIGURE 2. BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BIOLOGICAL SAMPLE HANDLING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BIOLOGICAL SAMPLE HANDLING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOLOGICAL SAMPLE HANDLING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOLOGICAL SAMPLE HANDLING MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLULAR & GENETIC MATERIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SALIVA SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STOOL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD COLLECTION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY NASAL SWABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY NASOPHARYNGEAL SWABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY OROPHARYNGEAL SWABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. BIOLOGICAL SAMPLE HANDLING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. BIOLOGICAL SAMPLE HANDLING MARKET, FPNV POSITIONING MATRIX, 2023